The U.S. Food and Drug Administration is ringing alarm bells over a potent, opioid-like substance that’s being sold in plain sight—often next to energy drinks, supplements, or flavored vapes. It’s called 7-hydroxymitragynine, or 7-OH, and it’s a concentrated compound derived from the kratom plant.You’ll find it in gummies, powdered drink mixes, flavored shots, and even ice cream cones. Sold mostly in gas stations, corner stores, and vape shops, these products look benign—but they’re not. According to the FDA, 7-OH has a high potential for abuse and no approved medical use. And now, after a sweeping scientific review, the agency is recommending that 7-OH products be added to the Controlled Substances Act (CSA)—in the same category as heroin and LSD.Here’s what this means, why it’s happening now, and what consumers should understand before they reach for that "all-natural" stress-relief gummy at the checkout counter.What Is 7-OH?Kratom is a tropical tree that grows natively in Southeast Asia. Leaves of the tree were used for centuries as a traditional herbal medicine. In the United States, kratom has become popular as an unapproved pain, anxiety treatment, and even opioid withdrawal alternative therapy. Some 1.7 million Americans age 12 and up used kratom in 2021, federal data suggest.Kratom has two major chemical constituents: mitragynine and 7-hydroxymitragynine (7-OH). The more prevalent and weakly active of these is mitragynine, whereas 7-OH is significantly stronger—directly affecting the brain's mu-opioid receptors, just like morphine or codeine.Some manufacturers have started isolating and concentrating 7-OH into high doses and selling it separately, completely bypassing the “natural” kratom leaf. These concentrated forms are not regulated, not approved, and far more dangerous than the kratom plant itself.Why Has FDA Issued A Warning?Unlike prescription opioids, 7-OH products are sold without a prescription or medical oversight, often labeled as supplements or energy enhancers. The FDA has found them being sold in brightly packaged gummies, fruity drinks, tablets, and “wellness shots,” frequently marketed to young people. Many of these items aren’t clearly labeled and may not disclose the amount of 7-OH they contain—or even that it’s included.In June, the agency sent warning letters to seven companies for illegally selling 7-OH products in violation of federal law. These companies were selling 7-OH in various forms and often making unverified health claims, such as pain relief, anxiety treatment, or arthritis relief—without any scientific evidence to back them up.According to FDA Commissioner Dr. Marty Makary, “7-OH is an opioid that can be more potent than morphine. We need regulation and public education to prevent another wave of the opioid epidemic.”The FDA’s latest report includes a clear recommendation: Schedule 7-OH as a controlled substance under the CSA. If accepted, this would make it illegal to sell, distribute, or possess 7-OH without special DEA approval. It would also allow for criminal penalties for unauthorized use.The Drug Enforcement Administration (DEA) is now reviewing the recommendation. Before any action is finalized, a public comment period will be held, as required by federal law.The agency made it clear that this action targets only 7-OH, not natural kratom leaf products. However, the distinction is critical, as 7-OH is not lawful in any food or dietary supplement in the United States. It has no FDA-approved uses, and when concentrated, it poses a high risk of abuse, addiction, and overdose.What Makes 7-OH So Risky?7-OH mimics the action of opioids in the brain by binding to the same mu-opioid receptors. While users may experience temporary relief from pain or anxiety, the effects can quickly lead to physical dependence, tolerance, and withdrawal symptoms—all hallmarks of substance use disorder (SUD). Some individuals using 7-OH have reported:Cravings and compulsive useNeeding higher doses over time to feel the same effectsWithdrawal symptoms when trying to stopContinued use despite serious personal or physical consequencesIn rare cases, deaths have been reported in connection with kratom and 7-OH use, though many involved polydrug interactions, making it hard to isolate the role of 7-OH alone. Still, the FDA is not waiting for a full-blown crisis before acting.Why Kratom Isn’t Safe Either?While the FDA’s current push is focused on 7-OH, kratom as a whole remains under scrutiny. The agency has not approved any kratom-based drug for treating any condition, and it cannot legally be sold as a dietary supplement or added to food. Products containing kratom are considered “adulterated” under the Food, Drug, and Cosmetic Act.That’s because, according to FDA analysis, there is insufficient evidence to guarantee that kratom—or its active compounds—can be safely used by consumers. The agency has linked kratom use to liver toxicity, seizures, and interactions with other medications.The U.S. is still recovering from a devastating opioid crisis, and regulators are keen to avoid repeating history with a new, under-the-radar substance. 7-OH’s legal gray zone, paired with its accessibility and potent opioid-like effects, makes it especially dangerous.The rise of vape shops and convenience store supplements has allowed these products to proliferate with minimal oversight. In many cases, they’re marketed using the same language as CBD or herbal wellness products—confusing consumers and bypassing safety checks.“This isn’t just about one compound,” said HHS Secretary Robert F. Kennedy, Jr. “It’s about building a framework that protects youth and families from unregulated, addictive substances dressed up as wellness solutions.”What You Should Do as a Consumer?The FDA is urging consumers to read labels carefully, avoid products that claim to contain kratom or 7-OH, and report adverse events. The agency is also encouraging healthcare professionals to speak openly with patients about supplement use—especially those purchased outside of pharmacies.Until thorough research proves safety and effectiveness, the risks of 7-OH far outweigh any perceived benefits. Consumers looking for help with pain, anxiety, or substance use disorders should consult licensed medical professionals—not convenience store counters.The push to regulate 7-OH underscores a growing challenge in public health: the intersection of wellness marketing, legal loopholes, and addictive substances. As agencies like the FDA and DEA step in, the public’s awareness and skepticism of “natural” supplements needs to catch up. Just because something is sold on a shelf doesn’t mean it’s safe.